Stocksigma LogoStocksigma Logo

Amerise Biosciences Reports Q2 FY27 Results with Widened Net Loss

Amerise Biosciences reported zero revenue from operations for Q2 ended 30th Sep'26, compared to nil revenue and other income of ₹6.75 lakhs in Q2 ended

Amerise Biosciences Reports Q2 FY27 Results with Widened Net Loss

Amerise Biosciences Ltd · Outcome · 30 Oct 2026, 10:11 pm

Amerise Biosciences Reports Q2 FY27 Results with Widened Net Loss Amerise Biosciences reported zero revenue from operations for Q2 ended 30th Sep'26, compared to nil revenue and other income of ₹6.75 lakhs in Q2 ended 30th Sep'25. Net loss for the quarter expanded to ₹5.76 lakhs versus a net loss of ₹4.23 lakhs YoY, driven by employee benefit expenses of ₹0.82 lakhs and other operating expenses of ₹4.94 lakhs. For H1 ended 30th Sep'26, net loss stood at ₹13.91 lakhs against ₹5.04 lakhs YoY. EPS for the quarter was ₹(0.01).

Original exchange filing (PDF)

More announcements from Amerise Biosciences Ltd

All Amerise Biosciences Ltd announcements